take the first step woman.png


Take the first step

Take control of your treatment with Faeth. Our precision nutrition is science-backed cancer treatment designed to starve your cancer of the nutrients it needs to survive and grow. 

We are committed to your fight, and to creating better cancer treatments for you and many others like you in the future.

Find out if you are eligible for a clinical trial

 


Why Faeth
 

faeth-program (3).gif

Preclinical studies show Faeth's precision nutrition diet may significantly slows cancer growth, increases survival time and dramatically increases the efficacy of standard treatments. With meals and snacks delivered to your door, therapeutics, and on-demand nutritional support from our team of expert Faeth Nutritionists, we're here to support your journey.


Join a clinical trial
 

Pik3CA Mutant Clear Cell Ovarian, Endometrial, Colorectal Cancers

SER-ISD1-001 - A Phase 1b Study of Serabelisib in Combination with an Insulin Suppressing Diet (Study ISD) in Adult Subjects with Advanced Solid Tumors with PIK3CA Mutations with or without PTEN loss

 

Locations

Memorial Sloan Kettering, New York NY

646-888-4224

makkerv@mskcc.org

 

Mayo Clinic, Rochester MN

855-776-0015

MAYOCLINICCANCERSTUDIES@mayo.edu

 

University of Texas Southwestern, Dallas TX 

214-648-7097

martha.cruz@utsw.edu

 

Pacific Cancer Specialists, Anaheim CA 

714-999-1465

elizabethg@pacificcancer.com

 

Hoag, Orange County CA

949-557-0290

cari.nelson@hoag.org

 

University of Alabama, Birmingham AL

205-975-2362

jspratlin@uabmc.edu

 

Medical College of Wisconsin, Milwaukee WI

414-805-6800

cccto@mcw.edu

 

East Carolina University, Greenville NC

252-816-2273

hemoncclinicaltrials@ecu.edu

 

University of Chicago, Chicago IL 

773-702-1000

cancerclinicaltrials@bsd.uchicago.edu

 

University of Pennsylvania, Philadelphia PA

You may still be able to participate in a study if you are not being treated at one of these sites. To find out if you may still be eligible, please reach out to our clinical trial partner, Anova Evidence at (224)-218-2408 or faeth@anovaevidence.com.

Coming soon to clinicaltrials.gov

Pancreatic Cancer

NEAAR 001 Study Medical Food for the Dietary Management of Metastatic Pancreatic Cancer

 

Locations

Cedars Sinai, Los Angeles CA 

310-423-1434

Shant.thomassian@cshs.org

 

Hoag, Orange County CA

949-557-0290

cari.nelson@hoag.org

 

Baylor Scott and White, Temple TX 

254-724-3796

Tnelda.Zunie@BSWHealth.org

 

SCRI-Tennessee Oncology, locations across TN

844-482-4812

N/A Email

 

SCRI-Florida Cancer Specialists South, Tampa FL

N/A

clinicaltrials@flcancer.com

 

Louisiana State University-Shreveport, Shreveport LA 

318-813-1058

lea.green@lsuhs.edu

 

Medical College of Wisconsin, Milwaukee WI

414-805-4639

badion@mcw.edu

 

Atlantic Health, Morristown NJ

973-971-6608

Nancy.Ginder@atlantichealth.org

 

Oklahoma University Health Sciences Center

University of Arizona Cancer Center

​You may still be able to participate in a study if you are not being treated at one of these sites. To find out if you may still be eligible, please reach out to our clinical trial partner, Anova Evidence at (224)-218-2408 or faeth@anovaevidence.com.

Learn more at ClinicalTrials.gov

Colorectal Cancer
 

NEAAR-002 Study Medical Food for the Dietary Management  of Metastatic Colorectal Cancer

 

Locations

Cedars Sinai, Los Angeles CA 

310-423-1434

Shant.thomassian@cshs.org

 

Hoag, Orange County CA

949-557-0290

cari.nelson@hoag.org

 

Verdi Oncology, Nashville TN 

Pacific Cancer Specialists, Anaheim CA 

University of Arizona Cancer Center, Tucson AZ

Memorial Sloan Kettering, New York NY

You may still be able to participate in a study if you are not being treated at one of these sites. To find out if you may still be eligible, please reach out to our clinical trial partner, Anova Evidence at (224)-218-2408 or faeth@anovaevidence.com.

Learn more at ClinicalTrials.gov

Pancreatic Cancer
 

PROMAP: A Medical Food Research Study for People with Pancreatic Adenocarcinoma (PDAC)

 

This is a study evaluating the tolerability and markers of pancreatic cancer with a specially designed medical food restricted in specific amino acids for the dietary management of subjects with pancreatic adenocarcinoma. Subjects will also receive their normal standard of care therapy.

Learn more at Xcures.com

Questions? Contact us, we're here to help

We are committed to your fight, and to creating better cancer treatments for you and many others like you in the future.


 


Learn more at ClinicalTrials.gov